Form 4: Clene Inc. Director Vallerie McLaughlin Acquires Stock Options
SEC Form 4
Director Vallerie McLaughlin was granted stock options for 3,138 shares of Clene Inc. common stock at an exercise price of $4.40 per share.
Summary
- Vallerie McLaughlin, a director at Clene Inc., was granted stock options on December 6, 2024.
- The options are for 3,138 shares of common stock.
- The exercise price for these options is $4.40 per share.
- The options vest immediately upon grant.
- The options expire on December 5, 2034.
Sentiment
Score: 7
Explanation: The document reflects a standard corporate practice of granting stock options to a director, which is generally viewed positively as it aligns interests. There is no indication of any negative or unusual activity.
Positives
- The grant of stock options to a director aligns their interests with those of the shareholders.
- Immediate vesting of the options may incentivize the director to contribute to the company's success.
Industry Context
Stock option grants to directors are a common practice in publicly traded companies to align management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a standard form of compensation for directors in publicly listed companies.
- The vesting schedule of immediately upon grant is not uncommon, but can vary by company and role.
- The exercise price of $4.40 per share is specific to Clene Inc. and would need to be compared to the current market price of the stock to assess its value.
Stakeholder Impact
- The stock option grant may have a minor positive impact on shareholder sentiment as it aligns director interests with company performance.
Key Dates
| Date | Description |
|---|---|
| 12/06/2024 | Date of the stock option grant. |
| 12/09/2024 | Date of the form filing. |
| 12/05/2034 | Expiration date of the stock options. |
Keywords
stock options, director, insider trading, equity, Clene Inc., CLNN
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.